LUNALDIN

Medicinal product

(Invented) name

LUNALDIN

Active substance (s)

Fentanilis

Strength

300 µg

Pharmaceutical form

poliežuvinės tabletės

Route (s) of administration

vartoti po liežuviu

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02AB03, Fentanyl

Marketing authorisation holder

Grünenthal GmbH, Vokietija

Date of authorisation

2009-04-10

Date of renewal

2014-07-01

Documents

LUNALDIN mokomoji medžiaga pacientams.pdf

1528 LUNALDIN RPP 2025 07 07.docx

1528 Pakuotės lapelis 2025 07 07.docx

LUNALDIN mokomoji medžiaga sveikatos prieziuros specialistams.pdf

Stage

Perregistruotas

Controlled?

Yes

Controlled substance type

Narkotinis

Legal basis

8(3)

Procedure number

SE/H/0575/004/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Fentanilis	300 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
20180	23253	1023253	lizdinė plokštelė	N10		Receptinis	LT/1/09/1528/007	Netiekiama	-	-	No	-	-	Download
35136	37472	1037472	lizdinė plokštelė	N30		Receptinis	LT/1/09/1528/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-07-01	Perregistruotas
2009-04-10	Registruotas